Total Payments
$326,304
2024 Payments
$38,047
Companies
15
Transactions
251
Payment Breakdown by Category
Other$190,128 (58.3%)
Consulting$91,272 (28.0%)
Travel$28,518 (8.7%)
Research$10,148 (3.1%)
Food & Beverage$6,227 (1.9%)
Gifts$11.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $183,548 | 65 | 56.3% |
| Consulting Fee | $91,272 | 19 | 28.0% |
| Travel and Lodging | $28,518 | 80 | 8.7% |
| Unspecified | $10,148 | 9 | 3.1% |
| Honoraria | $6,580 | 3 | 2.0% |
| Food and Beverage | $6,227 | 71 | 1.9% |
| Gift | $11.96 | 4 | 0.0% |
Payments by Type
General
$316,156
242 transactions
Research
$10,148
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOVERATIV THERAPEUTICS INC. | $113,053 | 70 | $0 (2021) |
| GENZYME CORPORATION | $72,286 | 43 | $0 (2024) |
| Novo Nordisk Inc | $41,971 | 33 | $0 (2021) |
| Shire North American Group Inc | $29,448 | 32 | $0 (2019) |
| BioMarin Pharmaceutical Inc. | $20,510 | 16 | $0 (2021) |
| Genentech USA, Inc. | $16,222 | 16 | $0 (2022) |
| PFIZER INC. | $12,100 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $11,117 | 13 | $0 (2024) |
| CSL Behring | $3,633 | 4 | $0 (2018) |
| Kedrion Biopharma Inc. | $3,200 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,047 | 23 | GENZYME CORPORATION ($27,784) |
| 2023 | $9,154 | 8 | GENZYME CORPORATION ($9,126) |
| 2022 | $16,393 | 15 | GENZYME CORPORATION ($9,653) |
| 2021 | $36,836 | 28 | GENZYME CORPORATION ($13,448) |
| 2020 | $26,125 | 21 | GENZYME CORPORATION ($12,276) |
| 2019 | $124,551 | 99 | BIOVERATIV THERAPEUTICS INC. ($62,734) |
| 2018 | $58,872 | 40 | BIOVERATIV THERAPEUTICS INC. ($35,006) |
| 2017 | $16,327 | 17 | Bioverativ Therapeutics Inc. ($9,402) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,909.00 | General |
| Category: Hematology | ||||||
| 09/27/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $12,465.00 | General |
| 09/27/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $366.65 | General |
| 09/27/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $344.17 | General |
| 09/27/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $267.97 | General |
| 09/27/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $219.70 | General |
| 07/18/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,726.00 | General |
| Category: Hematology | ||||||
| 07/18/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Travel and Lodging | In-kind items and services | $1,128.44 | General |
| Category: Hematology | ||||||
| 07/18/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Food and Beverage | In-kind items and services | $110.24 | General |
| Category: Hematology | ||||||
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $8,912.00 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $361.45 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $74.25 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $65.03 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $60.75 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $46.11 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $41.21 | General |
| 06/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $31.62 | General |
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $285.10 | General |
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $195.62 | General |
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $114.75 | General |
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $28.89 | General |
| 03/14/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $46.67 | General |
| Category: HEMATOLOGY | ||||||
| 03/08/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,246.50 | General |
| Category: Hematology | ||||||
| 12/08/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $8,337.50 | General |
| 12/08/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $359.53 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B | BIOVERATIV THERAPEUTICS INC. | $8,903 | 8 |
| Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment | BIOVERATIV THERAPEUTICS INC. | $1,245 | 1 |
About Dr. Michael Guerrera, MD
Dr. Michael Guerrera, MD is a Pediatrics healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548354723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Guerrera, MD has received a total of $326,304 in payments from pharmaceutical and medical device companies, with $38,047 received in 2024. These payments were reported across 251 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($183,548).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Hematology-Oncology, Pediatric Hematology-Oncology
- Location Washington, DC
- Active Since 10/03/2006
- Last Updated 03/31/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548354723
Products in Payments
- ALPROLIX (Drug) $52,957
- NO PRODUCT DISCUSSED (Drug) $24,839
- ELOCTATE (Drug) $19,954
- HEMLIBRA (Biological) $16,111
- ALTUVIIIO (Biological) $14,258
- ALPROLIX (Biological) $11,118
- ADVATE (Biological) $9,987
- NovoSeven RT (Drug) $6,483
- BENEFIX (Biological) $5,080
- Afstyla (Biological) $3,633
- CABLIVI (Biological) $2,924
- KOATE (Biological) $2,600
- SevenFact (Biological) $2,515
- ELOCTATE (Biological) $2,371
- NovoSeven (Biological) $1,700
- REBINYN (Biological) $1,700
- NovoSeven RT (Biological) $1,360
- Albuked (Biological) $600.00
- XYNTHA (Biological) $325.00
- Alphanate (Biological) $127.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Washington
Helen Thackray, Md, MD
Pediatrics — Payments: $4.6M
Pediatrics $4.6M
Dr. Ikechi Nnawuchi
Pediatrics — Payments: $654,155
Pediatrics $654,155
Brenda Martin, Np, NP
Pediatrics — Payments: $102,882
Pediatrics $102,882
David Nelson
Pediatrics — Payments: $22,971
Pediatrics $22,971
Gary Kupfer
Pediatrics — Payments: $22,067
Pediatrics $22,067
Dr. Nadia Merchant, M.d, M.D
Pediatrics — Payments: $21,940
Pediatrics $21,940